Guardion Health Sciences, Inc.

GHSI

US40145Q5009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-07 pm EDT			5-day change	1st Jan Change
9.9 ^USD	+0.30%		+3.88%	+85.39%

May. 31	Doctor's Best, Inc. completed the acquisition of Activ Nutritional, LLC. from Guardion Health Sciences, Inc..	CI
May. 13	Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Guardion Health Sciences, Inc. Announces the Resignation of Gordon Bethwaite as Vice President of Sales and Marketing

February 26, 2018 at 04:41 pm EST

Effective February 26, 2018, Gordon Bethwaite resigned from his position as Vice President of Sales and Marketing of Guardion Health Sciences, Inc. (the "Company"). Mr. Bethwaite indicated that his resignation was not due to any disagreement with respect to the company's operations, policies, or practices.

Latest news about Guardion Health Sciences, Inc.

Doctor's Best, Inc. completed the acquisition of Activ Nutritional, LLC. from Guardion Health Sciences, Inc..	May. 30	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
North American Morning Briefing : Hopes of March -2-	Feb. 05	DJ
Maxim Downgrades Guardion Health Sciences to Hold From Buy	Feb. 02	MT
Top Midday Gainers	Jan. 31	MT
Alphabet Earnings, Upcoming Fed Rate Decision Drive Mixed Premarket Action for US Equity Futures	Jan. 31	MT
Top Premarket Gainers	Jan. 31	MT
Doctor's Best, Inc. agreed to acquire Activ Nutritional, LLC. from Guardion Health Sciences, Inc. for $17.2 million.	Jan. 29	CI
Guardion Health Sciences Continues its Strategic Review Process	Nov. 13	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Guardion Health Sciences, Inc. Announces Executive Changes	23-07-31	CI
US Stock Futures Trend Higher Ahead of Consumer Sentiment Report	23-06-30	MT
Top Premarket Decliners	23-06-30	MT
Guardion Health Sciences, Inc. Announces Executive Changes	23-05-30	CI
Guardion Health Sciences, Inc. Announces CEO Changes	23-05-30	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
Guardion Health Sciences Hires Alantra, LLC as Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value	23-03-06	CI
Guardion Health Sciences Regains Compliance With Nasdaq Listing Rules	23-01-25	MT
Insider Buy: Guardion Health Sciences	23-01-11	MT
Guardion Health Sciences, Inc. announced that it expects to receive $4.75 million in funding	22-11-28	CI
Guardion Health Sciences Engages Financial Advisor to Conduct a Strategic Review Process	22-11-14	CI
Guardion Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI

Chart Guardion Health Sciences, Inc.

Duration

Period

More charts

Company Profile

Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. It sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.

Sector

Pharmaceuticals

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
GUARDION HEALTH SCIENCES, INC.	+85.39%	12.71M
ELI LILLY AND COMPANY	+45.82%	765B
NOVO NORDISK A/S	+40.95%	632B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.45%	248B
ROCHE HOLDING AG	-0.78%	219B
NOVARTIS AG	+11.88%	216B
AMGEN INC.	+5.90%	164B

Other Pharmaceuticals